Strategic Investment Holdings Llc Pfizer serves as Executive at Cortexyme, Inc., where they oversee executive responsibilities. Since joining the company, Strategic Investment Holdings Llc Pfizer has executed 1 insider transactions totaling $14.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 3, 2020 involved selling 370,000 shares valued at $14.9M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 3, 2020 | CRTX | $14.9M | Sale | 370,000 | $40.18 | Discretionary |
Strategic Investment Holdings Llc Pfizer currently holds 2,879,973 shares of Cortexyme, Inc. (CRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Strategic Investment Holdings Llc Pfizer has been a net seller of CRTX stock. They have purchased $0 and sold $14.9M worth of shares.
Strategic Investment Holdings Llc Pfizer's most recent insider trade was on Jun 3, 2020, when they sold 370,000 shares at $40.18 per share.
Get notified when new Form 4 filings are submitted